Professional Documents
Culture Documents
Anim Na Sabado NG Beyblade
Anim Na Sabado NG Beyblade
This essay won Second Prize for Sanaysay in the 2005 Palanca Awards
Malignant, immature white blood cells continuously multiply and are overproduced in the bone marrow.
ALL causes damage and death by crowding out normal cells in the bone marrow, and by spreading
(infiltrating) to other organs. ALL is most common in childhood with a peak incidence at 2–5 years of age,
and another peak in old age. The overall cure rate in children is about 80%, and about 45%-60% of adults
have long-term disease-free survival.[1]
Acute refers to the relatively short time course of the disease (being fatal in as little as a few weeks if left
untreated) to differentiate it from the very different disease of chronic lymphocytic leukemia, which has a
potential time course of many years. It is interchangeably referred to as Lymphocytic or Lymphoblastic.
This refers to the cells that are involved, which if they were normal would be referred to
as lymphocytes but are seen in this disease in a relatively immature (also termed 'blast') state.
Chemotherapy is the treatment of cancer with one or more cytotoxic antineoplastic drugs
("chemotherapeutic agents") as part of a standardized regimen. Chemotherapy may be given with
a curative intent or it may aim to prolong life or to palliate symptoms. It is often used in conjunction with
other cancer treatments, such as radiation therapy or surgery. Certain chemotherapeutic agents also
have a role in the treatment of other conditions, including ankylosing spondylitis, multiple
sclerosis, Crohn's disease, psoriasis, psoriatic arthritis, systemic lupus erythematosus, rheumatoid
arthritis, and scleroderma.
Traditional chemotherapeutic agents act by killing cells that divide rapidly, one of the main properties of
most cancer cells. This means that chemotherapy also harms cells that divide rapidly under normal
circumstances: cells in the bone marrow, digestive tract, and hair follicles. This results in the most
common side-effects of chemotherapy: myelosuppression (decreased production of blood cells, hence
also immunosuppression), mucositis (inflammation of the lining of the digestive tract), and alopecia (hair
loss).
Some newer anticancer drugs (for example, various monoclonal antibodies) are not indiscriminately
cytotoxic, but rather target proteins that are abnormally expressed in cancer cells and that are essential
for their growth. Such treatments are often referred to as targeted therapy (as distinct from classic
chemotherapy) and are often used alongside traditional chemotherapeutic agents in antineoplastic
treatment regimens.
An older and broader usage of the word chemotherapy encompassed any chemical treatment of disease
(for example, treatment of infections with antimicrobialagents). However, this usage has become archaic.
eyblade (爆転シュート ベイブレード Bakuten Shūto Beiburēdo?, lit. "Explosive Shoot Beyblade") is a
Japanese manga series written and illustrated by Takao Aokiin order to promote sales of spinning
tops called "Beyblades". Originally serialized in CoroCoro Comic from 2000 to 2002, the individual
chapters were collected and published in 14 tankōbon by Shogakukan. The series focuses on a group of
kids who form teams with which they battle one another using Beyblades.
The manga is licensed for English language release in North America by Viz Media. An anime adaptation,
also titled Beyblade and spanning 51 episodes, aired in Japan on TV Tokyo from January 8, 2001 to
December 24, 2001. The second, Beyblade V-Force, ran for another 51 episodes from January 7, 2002
until December 30, 2002. Beyblade G Revolution, the third and final adaptation, also spanned 51
episodes (the 51st was a double-length special but was split into two episodes for the Western release)
and aired from January 6, 2003, until its conclusion on December 29, 2003. Nelvana licensed the anime
for an English-language release.Takara Tomy also developed the Beyblade toy line.